Introduction: Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy. Aim of the work: The aim of this study is to compare the efficacy of metformin with that of insulin in treatment of gestational diabetes mellitus. Patients and Methods: This two armed clinical trial was conducted prospectively on 100 pregnant women on regular antenatal care in the Diabetic Clinic of Minia Maternity Hospital during the period from January 2016 to September 2017. Results: This study included 95 pregnant women having GDM, 47 of them were treated with metformin, and the remaining number (48) were treated with insulin. Conclusion: Approximately 80% of women with GDM could be successfully and safely treated with metformin when diet therapy and exercise fail to reduce blood glucose values sufficiently.
Gad El Rab, M., Yosef, A., & Kamel, Y. (2020). Oral Hypoglycemic Drugs Versus Insulin for the Management of Gestational Diabetes. Minia Journal of Medical Research, 31(2), 220-226. doi: 10.21608/mjmr.2022.221020
MLA
Mohammed T. Gad El Rab; Ayman M. Yosef; Yasser S. Kamel. "Oral Hypoglycemic Drugs Versus Insulin for the Management of Gestational Diabetes", Minia Journal of Medical Research, 31, 2, 2020, 220-226. doi: 10.21608/mjmr.2022.221020
HARVARD
Gad El Rab, M., Yosef, A., Kamel, Y. (2020). 'Oral Hypoglycemic Drugs Versus Insulin for the Management of Gestational Diabetes', Minia Journal of Medical Research, 31(2), pp. 220-226. doi: 10.21608/mjmr.2022.221020
VANCOUVER
Gad El Rab, M., Yosef, A., Kamel, Y. Oral Hypoglycemic Drugs Versus Insulin for the Management of Gestational Diabetes. Minia Journal of Medical Research, 2020; 31(2): 220-226. doi: 10.21608/mjmr.2022.221020
)
View on SCiNiTO